Patents by Inventor Duane Douglas Miller

Duane Douglas Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunosuppressive compounds and therapeutics
    Patent number: 10369133
    Abstract: Here provided are new immunosuppressive compounds and novel therapeutics for improving tissue transplantation.
    Type: Grant
    Filed: July 23, 2014
    Date of Patent: August 6, 2019
    Assignee: THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: Duane Douglas Miller, Charles Ryan Yates, Jayaprakash Pagadala, Ram Mahato, Hao Wu
  • Method for regulating retinal endothelial cell viability
    Patent number: 10010516
    Abstract: Here provided is a method for regulating retinal endothelial cell viability in a mammal by administering to the mammal a therapeutically effective amount of a quinic acid analog. The method may be applied to prevent, treat or cure pathological conditions of retinal endothelial cells associated with radiation retinopathy, diabetic retinopathy and chemotherapy for retinoblastoma.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: July 3, 2018
    Assignee: The University of Tennessee Research Foundation
    Inventors: Charles Ryan Yates, Jena Steinle Smith, Duane Douglas Miller, Jordan J. Toutounchian
  • Method for regulating retinal endothelial cell viability
    Patent number: 9566255
    Abstract: Here provided is a method for regulating retinal endothelial cell viability in a mammal by administering to the mammal a therapeutically effective amount of a quinic acid analog. The method may be applied to prevent, treat or cure pathological conditions of retinal endothelial cells associated with radiation retinopathy, diabetic retinopathy and chemotherapy for retinoblastoma.
    Type: Grant
    Filed: November 7, 2013
    Date of Patent: February 14, 2017
    Assignee: The University of Tennessee Research Foundation
    Inventors: Charles Ryan Yates, Jena Steinle Smith, Duane Douglas Miller, Jordan J. Toutounchian
  • IMMUNOSUPPRESSIVE COMPOUNDS AND THERAPEUTICS
    Publication number: 20160175281
    Abstract: Here provided are new immunosuppressive compounds and novel therapeutics for improving tissue transplantation.
    Type: Application
    Filed: July 23, 2014
    Publication date: June 23, 2016
    Inventors: Duane Douglas Miller, Charles Ryan Yates
  • Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation
    Patent number: 8906965
    Abstract: Disclosed are methods of use of analogs of quinic acids or shikimic acids for protection from the harmful effects of radiation when administered either prior to radiation exposure, after radiation exposure, or both. These methods are useful for treating humans and animals exposed to radiation and at risk for radiation sickness and/or death as the result of radiation exposure.
    Type: Grant
    Filed: May 11, 2010
    Date of Patent: December 9, 2014
    Assignee: The University of Tennessee Research Foundation
    Inventors: Charles Ryan Yates, Duane Douglas Miller, Mostafa Waleed Gaber, Karin Emmons Thompson, Kui Zeng, Jordan J. Toutounchian
  • METHOD FOR REGULATING RETINAL ENDOTHELIAL CELL VIABILITY
    Publication number: 20140094518
    Abstract: Here provided is a method for regulating retinal endothelial cell viability in a mammal by administering to the mammal a therapeutically effective amount of a quinic acid analog. The method may be applied to prevent, treat or cure pathological conditions of retinal endothelial cells associated with radiation retinopathy, diabetic retinopathy and chemotherapy for retinoblastoma.
    Type: Application
    Filed: November 7, 2013
    Publication date: April 3, 2014
    Applicant: The University of Tennessee Research Foundation
    Inventors: Charles Ryan Yates, Jena Steinle Smith, Duane Douglas Miller, Jordan J. Toutounchian
  • Anti-Inflammatory Quinic Acid Derivatives for Radioprotection/Radiomitigation
    Publication number: 20120283331
    Abstract: Disclosed are methods of use of analogs of quinic acids or shikimic acids for protection from the harmful effects of radiation when administered either prior to radiation exposure, after radiation exposure, or both. These methods are useful for treating humans and animals exposed to radiation and at risk for radiation sickness and/or death as the result of radiation exposure.
    Type: Application
    Filed: May 11, 2010
    Publication date: November 8, 2012
    Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: Charles Ryan Yates, Duane Douglas Miller, Mostafa Waleed Gaber, Karin Emmons Thompson, Kui Zeng, Jordan J. Toutounchian